ACIU AC Immune S.A.
Healthcare$2.83-0.70%ClosedMarket Cap: $288.0M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
6.94
P/S
60.94
EV/EBITDA
-3.27
DCF Value
$-0.04
FCF Yield
-31.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-1749.0%
Net Margin
-1788.8%
ROE
-124.0%
ROA
-48.2%
ROIC
-140.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.1M | 100.0% | $-14.8M | $-14.8M | $— | — |
| Q4 null | $338.0K | 100.0% | $-14.4M | $-14.4M | $— | — |
| FY null | $3.6M | 100.0% | $-68.9M | $-70.4M | $— | — |
| Q3 null | $939.0K | 100.0% | $-16.2M | $-15.9M | $— | — |
| Q2 null | $1.3M | 100.0% | $-19.4M | $-21.2M | $— | — |
| Q1 null | $990.0K | 100.0% | $-19.4M | $-19.0M | $— | — |
| Q4 null | $1.1M | 100.0% | $-18.6M | $-15.8M | $— | — |
| FY null | $27.3M | -129.1% | $-52.4M | $-50.9M | $— | — |
| Q3 null | $25.5M | 100.0% | $7.3M | $5.5M | $— | — |
| Q2 null | $687.0K | 100.0% | $-21.0M | $-22.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-20.1M | $-17.9M | $— | — |
| Q4 2023 | $14.8M | 100.0% | $-3.5M | $-4.7M | $-0.06 | — |